Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2008-01-15
2009-08-04
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C564S181000, C564S184000, C514S563000, C514S621000
Reexamination Certificate
active
07569723
ABSTRACT:
Compounds of formula (I):wherein R1, R2, R3, R4, R5and R6are as defined herein. The compounds are useful as reverse transcriptase inhibitors against HIV. In particular, the compounds are active against wild type and single or double mutant strains of HIV.
REFERENCES:
patent: 2004/0122064 (2004-06-01), Chan
patent: 2383782 (2001-03-01), None
patent: 1438973 (2004-07-01), None
patent: 0117982 (2001-03-01), None
patent: 0196338 (2001-12-01), None
patent: 02070470 (2002-09-01), None
patent: 03075907 (2003-09-01), None
patent: 2004009533 (2004-01-01), None
patent: 2004050643 (2004-06-01), None
Berge, et al; Pharmaceutical Salts; Journal of Pharmaceutical Science; Jan. 1977; vol. 66; No. 1; pp. 1-19.
Wyatt, et al: Benzophenone Derivatives: A Novel Series of Potent and Selective Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase; J. Med. Chem.; 1995; vol. 38; pp. 1657-1665; American Chemical Society.
Chan, et al; Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1; J. Med. Chem.; 2004; vol. 47; pp. 1175-1182; American Chemical Society.
Nader, et al; Synthesis of [carbonyl-11C]2-(2-benzoylphenoxy)-N-phenylacetamide from [11C]carbon monoxide by the Suzuki and the Stille reactions; Applied Radiation and Isotopes; 2002; vol. 57; pp. 681-685; Pergamon.
Balzarini, J.; Current Status of the Non-nucleoside Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Type 1; Current Topics in Medicinal Chemistry; May 2004; vol. 4(9); pp. 921-944.
De Clercq; The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection; Antiviral Research; 1998; vol. 38; pp. 153-179.
Pauwels; new non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections; Current Opinion in Pharmacology, Web Release: Aug. 24, 2004; pp. 437-446.
Pedersen, et al; Non-nucleoside reverse transcriptase inhibitors: the NNRTI boom; Antiviral Chemistry & Chemotherapy; 1999; vol. 10; pp. 285-314.
Andries, et al; TMC125, a novel next generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1; Antimicrobial Agents & Chemotherapy; Dec. 2004; vol. 48 (12); pp. 4680-4686.
O'Meara Jeffrey
Simoneau Bruno
Yoakim Christiane
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Kumar Shailendra
Morris Michael P.
Stempel Alan R.
LandOfFree
Benzoic acid derivatives as non nucleoside... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzoic acid derivatives as non nucleoside..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzoic acid derivatives as non nucleoside... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4052741